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Abstract 
Background. Patients with COVID-19 or post-COVID-19 will most probably have a need for 
rehabilitation during and directly after the hospitalization. Data on safety and efficacy are lacking. 
Healthcare professionals cannot wait for published randomized controlled trials before they can 
start these rehabilitative interventions in daily clinical practice, as the number of post-COVID-19 
patients increases rapidly. The Convergence of Opinion on Recommendations and Evidence 
process was used to make interim recommendation for the rehabilitation in the hospital and post-
hospital phase in COVID-19 and post-COVID-19 patients, respectively. 
Methods. 93 experts were asked to fill out 13 multiple choice questions. Agreement of 
directionality was tabulated for each question. At least 70% agreement on directionality was 
necessary to make consensus suggestions.  
Results. 76 experts (82%) reached consensus on all questions based upon indirect evidence and 
clinical experience on the need for early rehabilitation during the hospital admission, the 
screening for treatable traits with rehabilitation in all patients at discharge and 6-8 weeks after 
discharge, and around the content of rehabilitation for these patients. It advocates for 
assessment of oxygen needs at discharge and more comprehensive assessment of rehabilitation 
needs including physical as well as mental aspects 6-8 weeks after discharge. Based on the 
deficits identified multidisciplinary rehabilitation should be offered with attention for skeletal 
muscle and functional as well as mental restoration. 
Conclusions. This multinational task force recommends early, bedside rehabilitation for patients 
affected by severe COVID-19. The model of pulmonary rehabilitation may suit as a framework, 
particularly in a subset of patients with long term respiratory consequences.  
 
  
INTRODUCTION 
Globally, millions of people are infected with the severe acute respiratory syndrome coronavirus 
2, causing the coronavirus disease 19 (COVID-19) (1). A proportion of the of the confirmed COVID-
19 patients are admitted to the hospital for acute care, due to severe respiratory symptoms and in 
some cases even acute respiratory distress requiring prolonged mechanical ventilation (2).   
It is very likely that a proportion of the COVID-19 patients will have a need for rehabilitative 
interventions during and directly after the hospitalization (3-6). This approach is also 
recommended by the World Health Organization (7). However, data on safety and efficacy of 
rehabilitation during and/or after hospitalization in these patients are lacking. Equally, healthcare 
professionals cannot wait for well-designed randomized controlled trials to be published before 
they can start these rehabilitative interventions in daily clinical practice, as the number of COVID-
19 patients increases rapidly every day. 
Recently, Wilson and colleagues used the Convergence of Opinion on Recommendations and 
Evidence (CORE) process to make recommendations for the management of COVID-19 (8). The 
CORE process is a consensus-based approach to making clinical recommendations that has been 
shown to yield recommendations that are concordant with recommendations developed using 
Institute of Medicine-adherent methodology (9). The same methodology was used to develop 
interim guidance on rehabilitative interventions in the hospital and post-hospital phase in COVID-
19 patients pending empirical evidence.  
 
METHODS 
An ad-hoc international Task Force was assembled, including the European Respiratory Society 
(ERS) and American Thoracic Society (ATS) key opinion leaders as well as key opinion leaders and 
clinical experts from other relevant societies in the field of pulmonary rehabilitation. Invitations 
were sent to 93 experts within the field of pulmonary rehabilitation, respiratory and critical care 
medicine of physical medicine and rehabilitation. Seventy-six agreed to participate (82%). As 
described before (8), SurveyMonkey platform (SurveryMonkey, San Mateo, CA) was used to 
create 13-question multiple choice survey. Each question consisted of three parts: 1) presentation 
of the question in a modified PICO (Patient, Intervention, Comparator, Outcomes) format; 2) a 
multiple-choice question asking for strong or conditional recommendation for or against a course 
of action or no recommendation; and 3) a free text box for comments.  
After publishing an initial web-based blog on April 3rd 2020 and seeking global input (10), the core 
team of experts (MAS, AEH, SJS, TT) put together a list of possible relevant questions, and during 
three teleconferences, consensus was reached amongst about which question to maintain. 
Wording of the questions was adapted with input of ERS and ATS methodology teams to ensure 
unequivocal interpretation and consistency. The survey was not piloted in order to have more 
timely recommendations. 
The survey was administered once from April 27 to May 11, 2020, including several reminders. 
Agreement of directionality was tabulated for each multiple-choice question. At least 70% 
agreement on directionality was necessary to make consensus suggestions. The proportion of 
respondents per choice per question was calculated and expressed as a percentage of the total 
number of respondents. As more than 70% agreement on directionality was reached in all 
questions from the first round, no second round was necessary. 
   
RESULTS 
1. The international Task Force suggests that hospitalized patients with COVID-19 should 
receive rehabilitation at/around the bedside (critical care and/or ward based) until safe for 
discharge to the home environment. 
Rationale. Whilst most people infected with the COVID-19 virus have mild disease (11), some have 
more severe symptoms requiring hospital admission, and 20% of those admitted may require 
intensive care (12).  Hospitalised COVID-19 patients often have comorbidities, such as 
cardiovascular disease and diabetes (13) and may have prolonged hospital stays (14). Some 
COVID-19 survivors have physical impairments that may be exacerbated by prolonged immobility, 
including muscle weakness, neurological impairment and/or nutritional disturbance (15). In-
hospital rehabilitation could effectively address these problems (16). However there may be 
added challenges for rehabilitation delivery in the setting of COVID-19, related to infection 
prevention and changes to availability of existing rehabilitation services. 
Results. Majority of the experts recommended strongly (55%) or conditionally (37%) for 
hospitalised patients with COVID-19 receiving rehabilitation at/around the bedside (critical care 
and/ or ward based) until safe discharge to the home environment (Figure 1A; Table 1).  
Experts commented that patient-tailored early rehabilitative interventions similar to other 
critically ill patients should start after an assessment, including early mobilization and airway 
clearance. This may prevent and/or slow down the expected rapid deterioration in physical and 
emotional functioning. Some experts did express concerns about patients’ safety, due to the 
limited understanding of underlying pathophysiology and the possible impact of rehabilitative 
interventions. For example, it is unclear if there is any "threshold of illness severity" or any 
particular features of illness, which pose greater risk of patients undertaking rehabilitative 
interventions during hospitalization, including pulmonary, cardiovascular and/or neurologic 
manifestations of COVID-19 infection, in particular, the risk of clotting (micro thrombosis and 
venous thromboembolism). Moreover, the importance of appropriate personal protective 
equipment for the healthcare professional was mentioned by multiple experts as clear safety 
issue.     
 
2. The international Task Force suggests that prior to hospital discharge, hospitalised patients 
with COVID-19 should have an assessment of oxygen requirements at rest and during 
exertion. 
Rationale.  Hypoxemia is common in hospitalised patients with COVID-19, with hypoxic respiratory 
failure a prominent feature of severe cases (17). Whilst supplemental oxygen requirements 
reduce over time, alongside improvements in the underlying lung pathology (18), it is likely that 
some patients will have ongoing oxygen needs at hospital discharge.  Moreover, some patients in 
the recovery phase may have oxygen desaturation on exertion, which is not associated with 
resting oxygen saturation, the degree of dyspnoea or feeling unwell.  
Results. Majority of the experts recommended strongly (66%) or conditionally (26%) for 
hospitalised patients with COVID-19 having an assessment of oxygen requirements at rest and 
during exertion prior to hospital discharge (Figure 1B). 
Experts commented that assessment of oxygen requirements during exertion may vary between 
hospitals. However, low oxygen saturation may be a reason for additional assessment for 
pulmonary and cardiovascular comorbidities. Moreover, some patients do show a severe oxygen 
desaturation during physical exercise of only moderate intensity. Assessment of oxygen 
requirement prior to hospital discharge is necessary to prepare the individual COVID-19 patient 
with the needed equipment upon discharge home. A follow-up assessment on the re-evaluation 
of oxygen requirement should also be scheduled following hospital discharge, as supplemental 
oxygen may no longer be needed as the underlying lung pathology resolves.   
 
3. The international Task Force suggests that patients with COVID-19 should be encouraged to 
do regular daily activities in the first 6-8 weeks after hospital discharge. 
Rationale. Some patients with COVID-19 will resume daily activities without difficulty in the period 
following hospitalisation, but this may be more challenging in those who have had severe disease, 
prolonged hospital stays and/or persistent symptoms (19). About two-thirds of the survivors of 
other critical illnesses experience moderate-to-good recovery of physical function over the first 
two months (20). However recovery trajectories vary, with ongoing impairments most likely in 
older patients with longer ICU stays and greater sedation time (20).  
Results. Majority of the experts recommended strongly (58%) or conditionally (34%) for 
encouraging patients with COVID-19 to do regular daily activities in the first 6-8 weeks after 
hospital discharge (Figure 1C). 
Experts commented that recommencing daily physical activity as early as possible may positively 
affect functional recovery. However, patients may vary in physical, emotional and/or cognitive 
functioning. So, further assessment needs to be performed. Moreover, the encouragement to do 
regular daily activities should be in line with the local regulations for physical distancing and 
should go along with an advice to take time for recovery and rest periods, also taking an 
acceptable level of perceived exertion and dyspnoea and oxygen desaturation into consideration.  
 
4. The international Task Force suggests that patients with COVID-19 should be encouraged to 
do low/moderate intensity physical exercise at home (rather than high intensity physical 
exercise) in the first 6-8 weeks after hospital discharge, if a formal exercise assessment with 
measures of exertional desaturation has not been conducted. 
Rationale. COVID-19 infection is associated with a high inflammatory burden (21), which could 
persist beyond hospital discharge. Exertional desaturation may also persist, even in those without 
the requirement for supplemental oxygen at rest. Whilst moderate intensity exercise training is 
safe and feasible in survivors of critical illness (22), the safety of high intensity exercise in patients 
recovering from COVID-19 is unknown. During the early post hospital period it may not always be 
possible to conduct a robust exercise assessment or deliver supervised rehabilitation services, 
with uncertainties regarding the duration that patients remain infectious (23) and/or the need to 
maintain physical distancing.    
Results. Majority of the experts recommended strongly (29%) or conditionally (55%) for 
encouraging patients with COVID-19 to do low/moderate intensity physical exercise at home 
(rather than high intensity physical exercise) in the first 6-8 weeks after hospital discharge, if a 
formal exercise assessment with measures of exertional desaturation has not been conducted. 
(Figure 1D). 
Some experts stated that the potential benefits of low/moderate physical activity in preventing 
physical deterioration outweighed any perceived risks of undertaking such exercise without 
formal assessment. The low/moderate intensity physical exercises should be based on symptom 
limitation and tailored to the individual needs and limitations of the patients, which may vary 
largely. In addition to oxygen desaturation on exertion, experts encouraged health professionals 
to be aware of other possible causes of caution, like cardiomyopathy and (post-)pulmonary 
embolism.  
 
5. The international Task Force suggests that patients with COVID-19 should have a formal 
assessment of physical and emotional functioning at 6-8 weeks following discharge, to 
identify unmet rehabilitation needs. 
Rationale. Whilst good recovery of physical function should be expected over the first 8 weeks in 
most COVID-19 survivors, it is highly likely that there will be some with ongoing impairments in 
physical functioning (20). The high prevalence of post-traumatic stress disorder, cognitive 
impairment, chronic pain, sleep disorders, fibromyalgia, and fatigue in survivors of critical illness 
have been well documented (24-26). The COVID-19 pandemic gives rise to new psychosocial and 
emotional stressors for recovering patients, including social isolation, physical distancing, loss of 
employment and uncertainties about the future. 
Results. Majority of the experts recommended strongly (75%) or conditionally (22%) for patients 
with COVID-19 having a formal assessment of physical and emotional functioning at 6-8 weeks 
following discharge (Figure 1E). 
Experts stated that post-hospitalization recovery may vary considerably between patients, which 
justifies a formal assessment (including physical, emotional and cognitive functioning, and return 
to work) to customize rehabilitation care. Some experts also proposed an evaluation at hospital 
discharge to ensure patients were discharged to the appropriate setting (e.g., home, 
rehabilitation centre, nursing home), and to do only a formal assessment in symptomatic patients 
with limitations in daily functioning. 
  
6. The international Task Force suggests that follow up of a hospitalised patient with COVID-19 
should include the core outcomes set for survivors of acute respiratory failure at 6-8 weeks 
following hospital discharge. 
Rationale. Post-hospital outcomes of COVID-19 survivors are not yet understood. Assessment of 
physical and psychosocial outcomes following hospitalisation for COVID-19 will allow unmet 
rehabilitation needs to be addressed. A core outcome set allows essential outcomes to be 
consistently assessed using the same measurement instruments, so that data can be pooled and 
confident conclusions drawn. A core outcome set for survivors of acute respiratory failure has 
already been defined using a consensus process, and includes the EQ-5D, Hospital Anxiety and 
Depression Scale and Impact of Events Scale-Revised (27). The core outcome set does not include 
measures of cognition, muscle function, physical function or pulmonary function.  
Results. A majority of the experts recommended strongly (63%) or conditionally (30%) for the 
follow up of a hospitalised patient with COVID-19 including the core outcomes set for survivors of 
acute respiratory failure at 6-8 weeks following hospital discharge (Figure 1F) 
Experts recognized the importance of administering outcome measures that will help to identify 
the patients' need in order to direct, plan and devise appropriate interventions and resources to 
the patients and their caregivers. This may require multiple re-assessments at different time 
points (e.g., 3,6 and 12 months after hospital discharge). Individual experts suggested the 
addition of a tool to measure exertional breathlessness (e.g., the MRC dyspnoea grading scale) 
and cognitive screening (Montreal Cognitive Assessment) and alternative tools to assess the 
same domains as identified by Needham and colleagues (27) (e.g., Short-Form 36 to assess 
generic health status; the Primary Care Post-Traumatic Stress Syndrome (PTSD) questionnaire to 
assess symptoms of PTSD; Patient Health Questionnaire 9, General Anxiety Disorder 7, or the 
Depression Anxiety Stress Scale 21 to assess symptoms of anxiety and/or depression). Some 
experts believed that assessment at 6-8 weeks following hospital discharge is too soon, as some 
sequelae may manifest at later time points. Moreover, some experts indicted that community 
managed patients may also need a supported recovery programme.  
 
7. The international Task Force suggests that follow up of a hospitalised patient with COVID-19 
should include measures of respiratory function at 6-8 weeks following hospital discharge. 
Rationale. High resolution CT scans of the chest in patients with COVID-19 infection have shown 
significant respiratory abnormalities including ground glass opacities, inter- and intralobular 
septal thickening and consolidation. These changes start to resolve after 14 days, but may persist 
past hospital discharge (18). Long term follow-up of survivors of other severe viral pneumonias 
(SARS-COV-1 and MERS-COV) suggests that many had normal respiratory function at 1-year, 
although impaired diffusing capacity was evident in a minority (28, 29). Respiratory function 
testing is necessary to document ongoing impairments and guide future management, but it is 
considered an aerosol-generating procedure, which may limit its availability in the COVID-19 era. 
Results. A majority of the experts recommended strongly (45%) or conditionally (42%) for the 
follow up of a hospitalised patient with COVID-19 including measures of respiratory function at 6-
8 weeks following hospital discharge (Figure 1G). 
Experts recognized the importance of measuring respiratory function, as missing respiratory 
abnormalities are likely to lead to further decline and perhaps downstream new respiratory 
chronic disease. Experts emphasized to perform assessment only in patients with lingering 
respiratory symptoms and who were tested COVID negative in the post-hospitalization phase. 
Indeed, standard operating procedures need to be in place to prevent possible infection of other 
patients and/or the lung function technician. Some experts questioned whether local infection 
control protocols would allow measurements of respiratory function to be obtained. 
 
8. The international Task Force suggests that follow up of a hospitalised patient with COVID-19 
should include measures of exercise capacity at 6-8 weeks following hospital discharge. 
Rationale. Whilst the long-term consequences of Covid-19 are not fully understood, we know that 
the impact of an ICU stay for acute respiratory distress syndrome (ARDS) has a significant impact 
on physical function (30). Equally a protracted period of bed rest can have similar detrimental but 
partially reversible effects in chronic respiratory disease (31). There is some evidence that 
recovery in physical function is variable in ARDS survivors however the greatest recovery 
appeared to occur within the first two months (20).  An objective measure of exercise capacity 
(31) is important to document the degree of disability, identify the limitations to exercise and 
form the foundation of a subsequent rehabilitation programme. 
Results. Majority of the experts recommended strongly (61%) or conditionally (29%) for the follow 
up of a hospitalised patient with COVID-19 including measures of exercise capacity at 6-8 weeks 
following hospital discharge (Figure 1H). 
Many experts considered the measurement of exercise capacity to be very important in COVID-19 
survivors, but some experts believe that this measurement should be limited to patients who 
remain physically limited 6-8 weeks following hospital discharge and who are tested negative at 
the time testing the exercise capacity. Experts emphasized that assessors should be aware of the 
possible presence of cardiopulmonary sequelae. Some experts questioned whether local 
infection control protocols would allow measurements of exercise capacity to be obtained. 
 
9. The international Task Force suggests that COVID-19 survivors with a need for rehabilitative 
interventions at 6-8 weeks following hospital discharge (e.g., multiple treatable traits) 
should receive a comprehensive rehabilitation program, compared to no rehabilitation 
program. 
Rationale. Existing data from survivors of viral pneumonias indicates the wide range of challenges 
that patients face (20, 24, 25). It is unlikely that a unidimensional programme of physical training 
will meet the needs of the Covid-19 survivor as they will exhibit multiple treatable traits that a 
comprehensive rehabilitation programme has the potential to modify favourably. There is a 
limited evidence base for pulmonary rehabilitation post H1N1‐ARDS (32). The programme will 
potentially be wider in scope than current pulmonary rehabilitation programmes (33) to meet the 
needs of these individuals and consider the additional burden placed upon survivors as a 
consequence of this unique virus e.g. social isolation strategies and the associated emotional 
burden. Survivors may be of a different age group to the ‘usual’ pulmonary rehabilitation 
population and supporting a successful return to work will be important. 
Results. Majority of the experts recommended strongly (70%) or conditionally (26%) for COVID-19 
survivors with a need for rehabilitative interventions at 6-8 weeks following hospital discharge 
receiving a comprehensive rehabilitation programme (Figure 1I). 
Many experts commented on the diverse needs of COVID-19 survivors, such that not all survivors 
will need a comprehensive programme. Some experts commented that a comprehensive 
rehabilitation programme may not be available in all locations during the COVID-19 pandemic.  
 
10. The international Task Force suggests that COVID-19 survivors with pre-existing/ongoing lung 
function impairment at 6-8 weeks following hospital discharge should receive a 
comprehensive pulmonary rehabilitation program consistent with established international 
standards, compared to no pulmonary rehabilitation program  
Rationale. For patients with COPD there is evidence to indicate that recovery after an admission is 
supported by a structured rehabilitation programme. We know this is both safe and clinically 
effective and is recommended in national and international guidelines (33, 34). The current 
guidance for routine post-exacerbation pulmonary rehabilitation is 4 weeks post discharge, 
however the recommendation to delay this until 6-8 weeks post discharge was based upon the 
following considerations; there is a lack of data about the decay of the levels of infection in the 
Covid-19 survivor, the data suggesting that at 2 months a proportion of physical recovery will have 
occurred (20) and we also know that is a challenge for services to recruit patients to a post 
exacerbation rehabilitation programme 4 weeks post discharge (35). 
Results. Majority of the experts recommended strongly (70%) or conditionally (24%) for COVID-19 
survivors with pre-existing/ongoing lung function impairment at 6-8 weeks following hospital 
discharge receiving a comprehensive pulmonary rehabilitation program consistent with 
established international standards (Figure 1J). 
Experts recommended taking patient’s individual needs and preferences into consideration when 
decision regarding comprehensive pulmonary rehabilitation programs are made.  
 
11. The international Task Force suggests that COVID-19 survivors with loss of lower limb muscle 
mass and/or function at 6-8 weeks following hospital discharge should receive a muscle 
strengthening program, rather than no strengthening program. 
Rationale. For patients with ARDS, prolonged stay in the ICU mostly including  prolonged 
mechanical ventilation) is known to have significant impact on peripheral muscle function, 
reflected in a loss of muscle mass and power neuropathy and/or myopathy, that is better known 
as ICU-acquired muscle weakness (30), and occurs early on in the ICU stay (36). Equally, a 
prolonged period of bed rest can also have a significant effect in chronic respiratory disease (31). 
The lack of peripheral muscle strength can severely compromise functional ability and should be 
evaluated and treated as indicated (33). 
Results. Majority of the experts recommended strongly (80%) or conditionally (18%) for COVID-19 
survivors with loss of lower limb muscle mass and/or function at 6-8 weeks following hospital 
discharge receiving a muscle strengthening program (Figure 1K).  
Experts agreed that a muscle strengthening program was important to optimise recovery. 
Moreover, muscle strength needs to be assessed prior to commencement, to enable accurate 
prescription and tailoring of the strengthening program.  
 
12. The international Task Force suggests that COVID-19 survivors with loss of lower-limb muscle 
mass at 6-8 weeks following hospital discharge should receive nutritional support rather 
than no nutritional support. 
Rationale. It is well established that optimising caloric and protein intake is important to support 
recovery of functional muscle mass. The post-ICU COVID-19 survivor will face commonly reported 
problems with nutrition (e.g., loss of appetite, swallowing disorders) and the additional symptom 
of loss of taste (ageusia) and smell (anosmia) are now recognised symptom of COVID-19 (37). In 
general, for those with chronic respiratory disease weight loss and wasting of muscle and bone 
tissue may be induced or accelerated during severe acute exacerbations of respiratory disease 
requiring hospitalisation, due to the combination of malnutrition, physical inactivity, hypoxia, 
systemic inflammation and/or systemic glucocorticoids (38), this is likely to be mirrored in the 
COVID patient. 
Results. Majority of the experts recommended strongly (43%) or conditionally (36%) for COVID-19 
survivors with loss of lower-limb muscle mass at 6-8 weeks following hospital discharge receiving 
nutritional support (Figure 1L). 
Experts stated that rebuilding muscle mass requires that nutritional support is combined with a 
training stimulus. Moreover, experts believed that nutritional support may be less well 
established in some centres and guidance may be needed from expert sources.  
 
13. The international Task Force suggests that COVID-19 survivors with symptoms of 
psychological distress (using questionnaires) at 6-8 weeks after discharge from the hospital 
should receive a formal psychological assessment. 
Rationale. Common symptoms reported one year later by ICU survivors, including patient with 
ARDS, include anxiety (34%), depression (33%) and post-traumatic stress disorder (19%) (39).This is 
compounded for the post COVID-19 survivor by the emotional stress associated with social 
isolation from family and friends for a protected period of time as a consequence of government 
lockdown policies. There are questionnaires recommended in the core outcome data set that 
cover these aspects of anxiety and depression, alongside PTSD (27). It is also acknowledged that 
the emotional burden of COVID-19 is likely to extend beyond the individual to family and friends 
(40). 
Results. Majority of the experts recommended strongly (71%) or conditionally (24%) for COVID-19 
survivors with symptoms of psychological distress at 6-8 weeks after discharge from the hospital 
receiving a formal psychological assessment (Figure 1M). 
Experts believed that symptoms of anxiety, depression and PTSD occur commonly in persons 
after a major life event. Therefore, screening and monitoring of the course of symptoms of 
psychological distress is important. Experts also emphasized that those patients who show high 
level of anxiety or depressive symptoms needs to be referred to psychologist or psychiatrist for 
further assessment, and treatment may be indicated when symptoms continue to exist after 10-12 
weeks. Psychological assessment and support for the family of the infected patient was also 
emphasised by the experts. 
 
DISCUSSION 
The present study provides consensus-based suggestions for the screening and the rehabilitation 
process during and after a hospital admission for severe COVID-19 infection. Experts reached 
consensus based upon indirect evidence and non-systematic clinical observations (i.e., clinical 
experience) on the need for early rehabilitation during the hospital admission, the screening for 
treatable traits with rehabilitation in all patients at discharge and 6-8 weeks after discharge, and 
around the content of rehabilitation for these patients. In absence of a formal evidence-based 
approach, these findings provide interim guidance for referral and multidisciplinary rehabilitation 
in a subgroup of patients after hospital admission. Altogether the data cast a strong claim on the 
need for screening and rehabilitation options for patients who were hospitalized. Besides lung 
function testing (e.g., spirometry, whole-body plethysmography and carbon monoxide transfer 
factor) (41, 42), this screening should also contain at least an exercise test (cardiopulmonary 
exercise test, 6-minute walk test or shuttle walk test), muscle strength testing and patient-
reported outcome measures (19, 43-46). This cannot be ignored by health care systems 
organizing the care around this pandemic respiratory infection. It should be noted that several 
experts identified that during the pandemic there has been an absence of rehabilitation options 
for patients that suffered from COVID-19 . 
Early mobilisation and re-engagement in physical activity is important in the prevention of 
systemic consequences of a critical care and hospital admission. Whenever possible, patients 
should re-engage in physical exercise tailored to their possibilities. In patients suffering from 
COVID-19 such early interventions have to be balanced with the critical illness of the patient and 
the availability of personal protective equipment (PPE) for care givers engaged in the early 
mobilization protocols (5, 6, 47). Where rehabilitation staff are not available or cannot access PPE, 
some rehabilitation tasks at the bedside may be provided by other members of the 
multidisciplinary team, with appropriate instruction. At discharge from the hospital experts advise 
a first screening, particularly to investigate the need for oxygen supplementation, in order to 
guide the first weeks post discharge. Patients may still be infectious (48, 49), which may 
complicate testing outside the patient room. A one-minute sit-to-stand test has been proposed as 
a way to evaluate hypoxia on exertion in the patient’s room as an alternative to a six minute 
walking test (50), but needs further validation.  
After discharge, patients with COVID-19 should be encouraged to do low/moderate intensity 
physical exercise at home in the first 6 to 8 weeks. Usually, these tasks range between 1.5 and 6 
metabolic equivalents. Please see Ainsworth and colleagues for numerous examples (51, 52). 
Moreover, the guidance provided by the ATS/ERS statement on pulmonary rehabilitation (33) may 
serve as a good framework. In this statement, pulmonary rehabilitation is defined as : “… a 
comprehensive intervention based on a thorough patient assessment followed by patient-tailored 
therapies, which include, but are not limited to, exercise training, education, and behaviour change, 
designed to improve the physical and psychological condition of people with chronic respiratory 
disease and to promote the long-term adherence of health-enhancing behaviours.” Experts seem to 
agree that this definition also applies to the patient that suffered from severe COVID-19. Clearly 
there is a need for physiologic (statements 2, 5, 7, 8, and 11), psychologic (statements 5, 6, and 13) 
and nutritional (statement 13) assessment. For some patients there is a need for an individually  
tailored rehabilitation intervention (statement 9) and in the case of a pre-existing of remaining 
respiratory deficit, a pulmonary rehabilitation program (statement 10). Pulmonary rehabilitation 
programs are indeed well equipped to service this group of patients. Adaptations may need to be 
made to the rehabilitation program if the program typically deals with patients with obstructive 
lung disease to cater more to patients with gas exchange abnormalities. The self-management or 
education modules may also need to be adapted. It is expected that many patients that suffered 
from severe COVID-19 and particularly those with an ICU admission will have significant skeletal 
muscle weakness. Following muscle strength testing (46), s specific skeletal muscle training 
programs, typically offered with resistance training, are advised by experts. This is also the case in 
conventional pulmonary rehabilitation (53).   
To date no prospective studies exist in COVID-19 patients on the proportion of patients in need of 
some form of (multidisciplinary) rehabilitation. However, symptoms like fatigue and dyspnoea still 
occur frequently about 30 days after discharge from the hospital, and are accompanied by 
reduced quality of life in about 40% of the COVID-19 patients (19). In some cases, the program 
offered could be outside the pulmonary rehabilitation setting. Indeed, early studies from China 
and confirmed later (54) indicated that >30% of patients suffered from some neurologic and 
neuromuscular sequelae (55). It is yet unknown how much of this recovers spontaneously. The 
progression of functional, skeletal muscle and mental health status after an admission for COVID-
19 is not yet well described yet. Nevertheless, observational studies after SARS (56) or MERS (57) 
report an impaired 6-minute walk distance in 18% of the patients, and 43.6% had psychologic 
comorbidity. Hence health systems need to prepare to accommodate an increased number of 
referrals. 
The exact proportion of COVID-19 patients requiring rehabilitation are difficult to predict, but 
assuming that patients who received mechanical ventilation would be a minimum set of patients 
that require rehabilitation post discharge may provide a conservative estimate of the number of 
new rehabilitation cases. Taking the ISARIC, UK based database as an example, 10% of hospitalised 
patients required mechanical ventilation (58). In a US (New York) based cohort 23% of patients 
requiring mechanical ventilation (59). Unfortunately large proportions died in the ICU (e.g. up to 
60% in a study from New York, similar numbers in the ISARIC cohort), still rendering 40% of 
patients admitted to ICU as minimal numbers of new candidates for multidisciplinary 
rehabilitation, representing 5 to 10% of patients referred to hospital. Likely, a fraction of patients 
not mechanically ventilated (also including patients on high-flow oxygen therapy) will need to be 
added, as some of these still have significant functional consequences of the hospital admission 
(Belli et al. Under review ERJ; Paneroni et al. Under review ERJ). We strongly encourage countries to 
take action to organize rehabilitation for this influx of patients, on top of the many patients with 
chronic respiratory disease who already qualify for pulmonary rehabilitation (60).  
An issue not resolved, but of importance to the organisation of rehabilitation for these patients is 
the duration patients should be considered as infectious. There is currently no consensus on how 
long patients should be self- isolating. Local infection prevention recommendations should be 
followed and this may require significant adaptation of the rehabilitation program with for 
example the adoption of ‘tele-rehabilitation’ (61). The task force has adopted a 6-8 week time 
window for reassessment. At this time point (and likely even sooner) many patients will be 
considered non-infectious (48, 49, 62). 
A last point of attention is that despite the robust opinion in favour of rehabilitation after severe 
COVID-19 disease, these patients may be difficult to reach. Unfortunately several factors may 
preclude referral or uptake of rehabilitation. An important element that may impair uptake of 
rehabilitation is that at a population level rehabilitation might be hampered by pre-infection risk 
factors to be admitted to hospital with COVID-19, which include: having obesity, smoking and 
living an inactive life style (63). Moreover, it is known that COVID-19 disproportionately affects 
disadvantaged communities (64), many of whom have poor access to rehabilitation (65). These 
factors are known to impair uptake of rehabilitation. The offer for rehabilitation therefore need to 
be made to patients in a personalised and targeted manner, to maximise the likelihood of 
acceptance.  
  
  
Strengths and weaknesses  
While the present expert opinion paper followed rigorous methodology to reach consensus, and 
consensus was reached on all questions, some remarks need to be taken into account. It would 
be good to offer respondents the option of no response, as respondents may feel that they do 
not have adequate expertise to respond to a question or they may not understand the question 
wording. Indeed, some experts stated that there were composite questions, combining a 
question about the content of care with a question about timing. Moreover, sometimes questions 
may not have been very specific (e.g.  ‘measures of respiratory function’,  ‘measures of exercise 
capacity’, ‘comprehensive pulmonary rehabilitation program’ or ‘nutritional support’). Please see 
online Table 2 for all details. This may complicate interpretation of survey responses. We have 
taken, where possible written comments of the respondents into account. The current 
methodology also has strengths. It is fast and provides an interim guidance when randomized 
controlled studies are not yet available. Moreover, the current sample experts came from all over 
the world and had a diverse professional background, including medical but not limited to medical 
specialists, physiotherapists, nurses and psychologists.  
To conclude, this multinational task force recommends early, bedside rehabilitation for patients 
affected by severe COVID-19. It advocates for assessment of oxygen needs at discharge and more 
comprehensive assessment of rehabilitation needs including physical as well as mental aspects 6-
8 weeks after discharge. Based on the deficits identified multidisciplinary rehabilitation should be 
offered with attention for skeletal muscle and functional as well as mental restoration. The model 
of pulmonary rehabilitation may suit as a framework, particularly in a subset of patients with pre-
existing or COVID-19-induced long-term respiratory consequences.  
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DISCLAIMER 
The goal of consensus guidance is to standardize care, thereby improving outcomes and 
facilitating research. The suggestions in this document do not constitute official positions of the 
American Thoracic Society, European Respiratory Society, or the institutions of the Task Force 
members. They should not be considered mandates as no suggestion can incorporate all potential 
clinical circumstances. The suggestions are interim guidance that should be reevaluated as 
evidence accumulates. 
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1. Table 1. Interim recommendationsHospitalised patients with COVID-19 should receive 
rehabilitation at/around the bedside/critical care and/or ward based, until safe for 
discharge to the home environment. 
2. Prior to hospital discharge, hospitalised patients with COVID-19 should have an 
assessment of oxygen requirements at rest and during exertion. 
3. Patients with COVID-19 should be encouraged to do regular daily activities in the first 6-
8 weeks after hospital discharge 
4. Patients with COVID-19 should be encouraged to do low/moderate intensity physical 
exercise at home (rather than high intensity physical exercise) in the first 6-8 weeks 
after hospital discharge, if a formal exercise assessment with measures of exertional 
desaturation has not been conducted. 
5. Patients with COVID-19 should have a formal assessment of physical and emotional 
functioning at 6-8 weeks following discharge, to identify unmet rehabilitation needs. 
6. Follow up of a hospitalised patient with COVID-19 should include the core outcomes set 
for survivors of acute respiratory failure at 6-8 weeks following hospital discharge. 
7. Follow up of a hospitalised patient with COVID-19 should include measures of 
respiratory function at 6-8 weeks following hospital discharge 
8. Follow up of a hospitalised patient with COVID-19 should include measures of exercise 
capacity at 6-8 weeks following hospital discharge 
9. COVID-19 survivors with a need for rehabilitative interventions at 6-8 weeks following 
hospital discharge (e.g., multiple treatable traits) should receive a comprehensive 
rehabilitation program, compared to no rehabilitation program. 
10. COVID-19 survivors with pre-existing/ongoing lung function impairment at 6-8 weeks 
following hospital discharge should receive a comprehensive pulmonary rehabilitation 
program consistent with established international standards, compared to no 
pulmonary rehabilitation program 
11. COVID-19 survivors with loss of lower limb muscle mass and/or function at 6-8 weeks 
following hospital discharge should receive a muscle strengthening program, rather 
than no strengthening program 
12. COVID-19 survivors with loss of lower-limb muscle mass at 6-8 weeks following hospital 
discharge should receive nutritional support rather than no nutritional support. 
13. COVID-19 survivors with symptoms of psychological distress (using questionnaires) at 6-
8 weeks after discharge from the hospital should receive a formal psychological 
assessment. 
  
Figure 1. Experts’ responses to the 13 questions  
A. Q1. Should hospitalised patients with COVID-19 
receive rehabilitation at/around the bedside 
(critical care and/or ward based) until safe for 
discharge to the home environment? 
 
B. Q2. Prior to hospital discharge, should 
hospitalised patients with COVID-19 have an 
assessment of oxygen requirements at rest and 
during exertion? 
  
 
C. Q3. Should patients with COVID-19 be 
encouraged to do regular daily activities in the 
first 6-8 weeks after hospital discharge?  
 
 
 
 
 
D. Q4. Should patients with COVID-19 be 
encouraged to do low/moderate intensity 
physical exercise at home (rather than high 
intensity physical exercise) in the first 6-8 weeks 
after hospital discharge, if a formal exercise 
assessment with measures of exertional 
desaturation has not been conducted? 
 
E. Q5. Should patients with COVID-19 have a 
formal assessment of physical and emotional 
functioning at 6-8 weeks following discharge, 
to identify unmet rehabilitation needs?  
 
 
 
F. Q6. Should follow up of a hospitalised patient 
with COVID-19 include the core outcomes set 
(e.g., EQ-5D, Hospital Anxiety and Depression 
Scale, Impact of Events Scale-Revised, PMID: 
28699762) for survivors of acute respiratory 
failure at 6-8 weeks following hospital 
discharge? 
 
G. Q7. Should follow up of a hospitalised patient 
with COVID-19 include measures of respiratory 
function at 6-8 weeks following hospital 
H. Q8. Should follow up of a hospitalised patient 
with COVID-19 include measures of exercise 
capacity at 6-8 weeks following hospital 
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discharge? 
 
discharge? 
 
I. Q9. Should COVID-19 survivors with a need for 
rehabilitative interventions at 6-8 weeks 
following hospital discharge (e.g., multiple 
treatable traits) receive a comprehensive 
rehabilitation program, compared to no 
rehabilitation program? 
 
 
 
J. Q10. Should COVID-19 survivors with pre-
existing/ongoing lung function impairment at 6-
8 weeks following hospital discharge receive a 
comprehensive pulmonary rehabilitation 
program consistent with established 
international standards, compared to no 
pulmonary rehabilitation program? 
 
K. Q11. Should COVID-19 survivors with loss of 
lower limb muscle mass and/or function at 6-8 
weeks following hospital discharge receive a 
muscle strengthening program, rather than no 
strengthening program? 
 
 
L. Q12. Should COVID-19 survivors with loss of 
lower-limb muscle mass at 6-8 weeks following 
hospital discharge receive nutritional support 
rather than no nutritional support? 
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M. Q13. Should COVID-19 survivors with symptoms 
of psychological distress (using 
questionnaires) at 6-8 weeks after discharge 
from the hospital receive a formal 
psychological assessment? 
 
  
 
Legend figure: + + = Strong recommendation for …; + = Conditional recommendation for …; +/- = 
No recommendation for or against; - = Conditional recommendation against …; - - = Strong 
recommendation against … 
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Online Table 1. The following experts have filled out the survey and agreed to be mentioned in 
this overview (alphabetical by country) 
Name Background Country 
Jacqui Kay Physiotherapist Australia 
Jane Malone 
Physical Medicine & 
Rehabilitation Australia 
Kimberley Haines Physiotherapist Australia 
Narelle Cox Physiotherapist Australia 
Steven Faux 
Physical Medicine & 
Rehabilitation Australia 
Sue Berney Physiotherapist Australia 
Ralf Harun Zwick Pulmonologist Austria 
Andreas von Leupoldt  Psychologist Belgium 
Chris Burtin Physiotherapist Belgium 
Daniel Langer Physiotherapist Belgium 
Grégory Reychler Physiotherapist Belgium 
Heleen Demeyer Physiotherapist Belgium 
Fabio Pitta Physiotherapist Brazil 
Fernanda Lanza Physiotherapist Brazil 
Vinicius Maldaner Physiotherapist Brazil 
Diana Hopkins-Rosseel Physiotherapist Canada 
Didier Saey Physiotherapist Canada 
Natalja Tchajkova 
Physical Medicine & 
Rehabilitation Canada 
Roger Goldstein  Pulmonologist Canada 
Rodrigo Torres Physiotherapist Chile 
Homer Yu Pulmonologist China 
Weili Wei Pulmonologist China 
Jhonatan Betancourt-Pena Physiotherapist Colombia 
Vicente Benavides Physiotherapist Colombia 
Katerina Neumannova Pulmonologist Czech Republic 
Henrik Hansen Physiotherapist Denmark 
Maurice Hayot Pulmonologist France 
Rainer Gloeckl Sport scientist Germany 
Rembert Koczulla Pulmonologist Germany 
Janos Varga Pulmonologist Hungary 
Bruno Balbi Pulmonologist Italy 
Enrico Clini Pulmonologist Italy 
Guido Vagheggini Pulmonologist Italy 
Mara Paneroni Physiotherapist Italy 
Michele Vitacca Pulmonologist Italy 
Stefano Belli Physiotherapist Italy 
Atsuyoshi Kawagoshi Physiotherapist Japan 
Tetsuao Miyagawa Physiotherapist Japan 
Yutaro Oki Physiotherapist Japan 
Alex van 't Hul Physiotherapist Netherlands 
Anne-Loes van der Valk Physiotherapist Netherlands 
Daisy Janssen Elderly care specialist Netherlands 
Marike van der Schaaf Physiotherapist Netherlands 
Anita Grongstad Physiotherapist Norway 
Anne Edvardsen Physiotherapist Norway 
Bente Frisk Physiotherapist Norway 
Alda Marques Physiotherapist Portugal 
Paulo Abreu Physiotherapist Portugal 
Antonio Rios Physiotherapist Spain 
Elena Gimenos-Santos Physiotherapist/psychologists Spain 
Andre Nyberg Physiotherapist Sweden 
Karin Wadell Physiotherapist Sweden 
Malin Nygren-Bonnier Physiotherapist Sweden 
Isabelle Fresard Pulmonologist Switzerland 
Deniz Inal-Ince Physiotherapist Turkey 
Melda Saglam Physiotherapist Turkey 
Anne-Marie Doyle Psychologists UK 
Arietta Spinou Physiotherapist UK 
Claire Nolan Physiotherapist UK 
Enya Daynes Physiotherapist UK 
Ioannis Vogiatzis Exercise physiologist UK 
Joy  Conway Physiotherapist UK 
Linzy Houchen Physiotherapist UK 
Matthew Maddocks Physiotherapist UK 
Rachael Evans Pulmonologist UK 
Will Man Pulmonologist UK 
Abebaw Yohannes  Physiotherapist US 
Angela Campbell Physiotherapist US 
Carolyn Rochester 
Pulmonologist/critical care 
specialist US 
Chris Garvey Nurse US 
Chris Wells Physiotherapist US 
Dale Needham 
Pulmonologist/critical care 
specialist US 
Linda Nici 
Pulmonologist/critical care 
specialist US 
Melissa Bednarek Physiotherapist US 
Rebecca Crouch Physiotherapist US 
Surya Bhatt 
Pulmonologist/critical care 
specialist US 
 
  
Online Table 2. All comments by the members of the expert panel 
COVID‐19: Interim Guidance on Rehabilitative Interventions in the Post-
Hospital Phase Pending Empirical Evidence 
Should hospitalised patients with COVID-19 receive rehabilitation at/around the 
bedside (critical care and/or ward based) until safe for discharge to the home 
environment? 
Comments 
Rehab (or part) should be installed as soon as possible to prevent avoidable impact of physical 
inactivity.  
 Recommendation similar to other critically ill patients  
as long as possible to do in a safe manner for the rehab professional 
As the acute pathology of these patients continues to be elucidated, I would be cautious 
regarding the amount and intensity of any exercise intervention in the acute setting. I am 
primarily thinking of the findings of significant vascular compromise both in the lungs and in 
other end-organs including the brain- these patients may behave much more like our pulm HTN 
patients and therefore recognition and ability to treat and react to decompensation will be crucial 
authors need to define rehabilitation and state of patient 
Case-by-case decision balancing severity of symptom presentation with safety in the form of 
appropriate PPE available for the caregiver. 
Currently available research supports early intervention for mobilization of critically ill patients to 
avoid progressive muscle weakness, loss of bone density, and facilitate airway clearance and 
breathing mechanics. 
Depending on the rehabilitation. Passive mobilization for sedated patients seems not 
recommended but all the other rehabilitation are strongly recommended 
Depends on the definition of 'rehabilitation'. All patients should have assessments of their 
function and have appropriate physiotherapy with the aim of discharge (including early 
mobilisation in critical care). 
 
If this is referring to exercise training then there isn't a positive evidence base to support this in 
other conditions. It would be reasonable to discuss a discharge recovery programme. 
Factors limiting strong recommendation are limited understanding  of manifestations and 
effective management of this disorder and variable resources and guidelines for effective and 
safe clinical care.  
For critical care COVID19 cohorts - the evidence-based care of these patients within ICU/wards 
should be informed by the existing critical care rehabilitation literature for acute respiratory 
failure and general critical care rehabilitation literature (although some existing trials are 
negative, neutral, inconclusive). See this example: 
 
https://jamanetwork.com/journals/jama/article-abstract/2530536 
 
 
 
Other examples: 
 
https://www.sciencedirect.com/science/article/pii/S0003999310000341 
 
https://www.sciencedirect.com/science/article/abs/pii/S1036731420300552 
 
https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201606-484OC 
 
https://www.atsjournals.org/doi/full/10.1164/rccm.200505-693OC 
 
 
 
 
 
There are decades of critical care research in ARF and ARDS that should inform care of 
COVID19 cohorts (given they can present to ICU with ARF and ARDS). 
High risk for disease transmission, especially in settings of limited PPE.  
I agree only if the therapist is sufficiently safe from infection. 
If you do not activate those patients at/around the bedside, it would be critical to discharge them 
safe and quick to home environment. If those patients get home, they have to do more than they 
were used in the hospital.  
Individually adjusted 
It is important to evaluate each patient and devise a treatment plan that is according to their 
need. As the evidence for  specific intervention for the COVID-19 patients is not entirely clear at 
this stage.  
Lack of any rehabilitation poses dire risk of severe decline in functional status for hospitalized 
patients; those who require ICU care;  especially those who require prolonged sedation, 
mechanical ventilation and/or neuromuscular blockade and/or who receive systemic 
corticosteroids are at major risk of critical illness neuromyopathy.  As such, provision of 
rehabilitation as able during the hospital stay is of major importance. 
 
 
 
The basis of my conditional recommendation for hospital based rehab pertains to safety issues 
for patients and staff: 
 
Issues are: 
 
1. adequate PPE is needed for provision of rehabilitation to patients infected with COVID 19 and 
there is as yet no clear data to guide the level of risk to healthcare workers of acquiring COVID-
19 from delivering PT to these persons 
 
2. adequate testing should be available for healthcare professionals who do provide rehab to 
patients infected with COVID 
 
3. safety of providing rehab to people with severe respiratory involvement (pneumonia and/or 
ARDS) from COVID with severe hypoxemia and/or other cardiovascular or neurologic 
manifestations of COVID is not clear--in particular, the risk of clotting (micro thrombosis and 
venous thromboembolism) is a concern (in terms of PE, MI, stroke and limb ischemia risk). 
Important that we DO NO HARM, and the risks of rehab in this population as compared with 
risks for non-COVID hospitalized patients is unclear at present.  
 
4. Also unclear if there is any "threshold of illness severity" or any particular features of illness 
related to COVID which poses greater risk of patients undertaking rehab during hospitalization 
Rehabilitation is recommended only when the patient tolerates the activities and exercises that 
are administered, mainly in symptoms and physiological variables. 
Severaly or critically ill patients should not receive ICU pulmonary rehabilitation, 
https://pubmed.ncbi.nlm.nih.gov/32251002/. in addition, an increase in biomarkers of cardiac 
injury has been documented https://pubmed.ncbi.nlm.nih.gov/32252591/ . 
 
 
 
Activities such as positioning and early mobilization would be recommended depending on the 
stability of the patient 
Some patients would benefit from specialised equipment that would require them to leave their 
bedside. 
The rehab has to be applied safety. 
There are some definition issues here as to whatconstitutes PR in this location. I think a 
modified program is of value. The issue of course is PPE for staff and to what extent patients 
are treated individually versus in a class.  
Use of personal protective equipment is an absolute necessity for direct patient care. Acute care 
may be limited to prone positioning, and passive and active early mobilization if the patient is 
hemodynamically stable, and the level of sedation permit to apply. Acute care include direct 
patient contact.  
 
For relatively less ill patients who are relatively active, are able to perform self care activities, 
being active and mobilization may be adequate. Those patients may do light activities in and 
around the bed under supervision, if possible using in hospital tele-health options, and leaflets 
may be given. 
We have sepsis data  
 
WBV seems to be safe  
 
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Prior to hospital discharge, should hospitalised 
patients with COVID-19 have an assessment of 
oxygen requirements at rest and during exertion? 
 Comments   
early insights indicate that an oxygen transport deficiency is 
present in many patients in the recovery phase and is not 
always accompanied by dyspnea. Some patients show severe 
desaturation during  exercise of only moderate intensensity 
 
In my opinion NOT ALL patients should be assessed of 
Oxygen requirements at rest and during exertion. Only on 
indication 
 Will split response 1) all patients should have a daily 
assessment of resting oxygen saturation prior to discharge  
 
Pre-discharge ambulatory oxygen assessments are a difficult 
issue where practice varies internationally even in COPD.  
 
Many hospitalised patients with COVID19 will have exertional 
hypoxaemia pre discharge even if resting oxygen saturation is 
reasonable (and many clinicians have lowered reasonable to 
be 92-94% on air) but this will likely recover. More important 
that this is reassessed after discharge. 
 
My personal opinion is that post-hospital ambulatory oxygen 
should only be prescribed where symptoms (exertional 
breathlessness) are preventing discharge (not degree of 
exertional hypoxaemia - where events related to hypoxaemia 
are extremely low) and supplemental oxygen appears to help. 
Another caveat would be if there is an underlying condition 
which is complicated by the hypoxaemia such as angina or 
cardiac arrhythmia. 
 
Again some qualification is needed about 'assessment' - I am 
assuming this is referring to a standardised walking test on 
and off oxygen.  
 
evidence that patient do not report feeling unwell despite 
having low sats and there is an increase in the incidence of 
VTE in covid 
 Assuming the patient presented with pulmonary symptoms. 
 
There needs to be a distinction between those patients with 
underlying chronic respiratory diseases and those patients 
without the disease who contracted COVID-19. If those 
patients with chronic respiratory disease before admission had 
long term oxygen therapy then it is important to reassess their 
need for oxygen therapy.  The re-assessment before 
discharge will help to  increase or decrease their oxygen 
need. Those without respiratory disease, if they recover from 
the COVID-19, condition is stable they might not need an in-
depth investigation.  
 People from ICU suffer from sarcopenia, critical illness 
poöyneuropathia and respiratory insufficience-  
 Although a reassessment will likely be necessary after 1 
month. 
 I believe that step test is a good way to determine the 
assessment of O2. 
 NOTT and BMR trials support supplemental oxygen for 
hypoxemic patients at rest.  Supplemental oxygen is also 
recommended (and reimbursed by Medicare in the USA) for 
those patients who desaturate with activity below 85-88% 
SpO2. 
 
This must be assessed prior to hospital discharge to prepare 
the COVID patient with needed equipment upon discharge 
home. 
 
If possible should oxygen requirements both at rest and during 
exertion be assessed. There is at the moment no 
standardised follow up plan i Norway and it may take quite a 
long time before especially exercise desaturation could be 
found. As far as I know has oxygen requirement at exertion 
not been performed. Maybe should the choice be "strong".. 
 If execise not contraindicated 
 
This is more likely to occur throughout the hospital stay 
through regular nursing and physiotherapy assessments, 
rather than a specific assessment prior to hospital discharge. 
There will be patients however who need to have an 
assessment of oxygen requirements as a result of their 
COVID-19 diagnosis.  
 assessment at rest: yes 
 
assessment during exertion: not standard 
 
The evaluation of oxygenation at rest and during exercise 
should be applied in patients who had complications or ICU 
admission, it has been documented interlobular septal 
thickening and air bronchus sign as well as consolidation, 
fibrosis and air trapping: pubmed.ncbi.nlm.nih.gov/32272262/. 
 
 
 
For evaluation of oxygen durin exertion, field tests to avoid the 
risk of cross infection should be avoided and tests such as Sit 
To Stand performed in the same patient room should be tried. 
 
This does not need to be formalized testing but can be part of 
basic activities that RN engages patient. IF functional status is 
at question for save discharge than a PT/OT consult would be 
appropriate. They can complete the O2 assessment 
 
Yes to the extent that it is possible to assess patients' 
exertional needs safely; It is important to know what the O2 
requirements are before discharge 
 I am not sure toperform a six minute walk test or a similar test 
at this stage to assess exercise oxygen requirements.  
 
Absolutely necessary since it depends on achieving medium-
term goals and being able to perform pulmonary rehabilitation 
with orientations to the needs of each patient. On the other 
hand, the information provided could be a predictor of 
morbidity and mortality, as in some cases of pulmonary 
fibrosis or pulmonary insterstitial disease. 
 
Suggest to assess if they respond to oxygen during exertion. 
Those who respond positive may be discharged with oxygen 
to use during exertion. However, close monitoring is needed 
to assess whether the patient may have requirements of 
supplemental oxygen.  
 
A follow-up assessment on the re-evaluation of oxygen 
requirement should also be scheduled with Hospital discharge 
because it might be assumed that many COVID patients might 
need supplemental oxygen only on the short-term but not on 
the Long-term.  
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should patients with COVID-19 be encouraged to do 
regular daily activities in the first 6-8 weeks after 
hospital discharge? 
 Comments   
Restart physical activity as early as possible may positively 
affect functional recovery. A problem in this respect is 
however the frequently observed desaturain on exertion of 
even moderate intensity. Therefore, patients should be given 
good personalized advise on discharge from the hospital on 
the intensity of the activities. 
 
Advice to slowly regain regular daily activities are 
recommended but this should go along with the advice to take 
time for recovery and rest periods 
 hall mark for pulm rehab once safe to be sent home  
 
assists in clearing of the lungs, quality of life and endurance 
and function 
 With physical distancing.  
 
I agree there is evidence from the published literature regular 
daily activities e.g. regular walking has potential benefits for 
patients with chronic respiratory diseases.  
 Rule out that cardiac problems occured 
 Question way too vague to complete this item. 
 
Too many variables: 
 
Disease severity 
 
Definition of regular daily activities -- depends on patient's 
usual, occupation demands etc.  
 Borg level three of exertion , therefore unlikely to return to 
complete normal activity but need a routine program  
 Yes modified to enhance mobilization- 
 
COVID-19 delivers a significant insult to the pulmonary 
system.  Research has shown a benefit for comprehensive 
Rehabilitation following an acute injury to the lungs or 
exacerbation of known lung disease.  
 Strongly need of FITT definition and monitor control 
 
Our experience so far is that the patients differ significantly in 
fucnrional (both physical and psychological) status after 
hospital discharge - with a lot of patients with confusion. 
Therefore the conditional recommenation before further 
assessment has been performed. 
 I agree only if the therapist is sufficiently safe from infection. 
 No data available  
 
Imoprtant to teach them about accepatble level of preceived 
exertion or dyspne, for example Borg's RPE and Borg's CR-10 
 
But it is important that we monitor the patient with oxygen 
measurement in rest and daily activities, Borg-score at daily 
activities  
 We need to improve peripheral muscle function and 
metabolism. 
 based on the individual situation and abilities 
 Because the functional recovery of a critically ill patient can 
take months, there is still no consistent evidence on the 
contribution of rehabilitation in the first six weeks; and being 
an infectious disease with risk of reinfection, a home 
rehabilitation plan should be first for a subsequent evaluation 
and admission to pulmonary rehabilitation 
https://pubmed.ncbi.nlm.nih.gov/28463657 
https://pubmed.ncbi.nlm.nih.gov/24413580/. 
 
 
 
However, these patients could scale in the execution of 
activities of daily living in their first days after hospitalization, 
with general recommendations and supervision. 
 
This will depend on the functional status at time of discharge, 
degree of ability to perform ADLs independently or with 
assistance in the home, and on whether there are ongoing 
problems with oxygenation, and/or any limiting 
cardiocirculatory and/or neurologic factors.  Also, beyond 
deconditioning, we do not yet know what the muscle 
manifestations of COVID-19 are. Many patients experience 
muscle pain as a manifestation of their infection. We do not 
yet know whether activity (and what level of it) may be 
beneficial for recovery, versus potentially leading to some 
longer term harm (this also is relevant to conditional 
recommendation for hospital-based rehab in question 1). 
 Patients should be encouraged to do light activities.  
 
It should be encouraged only if the patient has had a previous 
evaluation. That includes, use of medications, use of oxygen, 
comorbidities, functional limitations and aerobic capacity. 
 
only low intensity 
 A caveat might be guidance on SaO2 monitoring as well as 
HR initially 
 
Individaully adjusted at a moderate intensity assessed by a 
symptom scale. Close monitoring will be needed to asure that 
worsened respiratory symptoms are detected. 
 
Probably some safety limits should be included like "regular 
physical activities with respect to the individuals limitation" or 
similar 
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should patients with COVID-19 be encouraged to do 
low/moderate intensity physical exercise at home 
(rather than high intensity physical exercise) in the 
first 6-8 weeks after hospital discharge, if a formal 
exercise assessment with measures of exertional 
desaturation has not been conducted? 
 Comments   
Patients recovery from covid-19 show marked heterogeneity 
in the exercise capacity and pulmonary impairments. This 
precludes a one-size fots all advice with respect to exercise 
intensity. 
 Similar to Q2 - there is too much concern about complications 
from exertional hypoxaemia which are rare. The individuals 
underlying complications from COVID19 need to be 
understood i.e cardiomyopathy, pulmonary emboli where 
caution would be advised. I expect cardiac instability is the 
greater cause for caution.  
 
 
 
It maybe that high intensity exercise is not achievable due to 
post-COVID muscle fatigue etc, but I wouldn't make the 
caution about high intensity to be around hypoxaemia.  
 
 
 
For clarity, agree with recommendation about low/moderate 
exercise during recovery until safety assessment (it is the 
issue about exertional desaturation driving my 
recommendation 'against') 
 only if too frail or old to sweat effiently 
 
The risk of deterioration is greater without low to moderate 
exercise than it is to do the exercise without formal 
assessment. Symptom-limited recommended. 
 Should Be Seen at least by GP in advance  
 
Again - vague question. Need to define intensity. We are 
finding very high perceived exertion levels (one measure of 
intensity) at low MET levels with some patients (another 
measure of intensity). 
 More evidence for benefit versus not 
 
We might be placing an unecessarily high value on formal 
assessments especially at this point. If the initial goals are 
improvements in peripheral muscle function as well as general 
mobilization I would be comfortable proceeding with 
exercising to symptom limitation-provided the therapist had 
experience in PR. However, there is no reason not to provide 
the patient with a simple finger pulse oximeter to know 
baseline and exercise saturation profiles. This might be more 
important post COVID because of the oxygenation profile. 
 
Considering the virus dissemination and the social restriction, 
I believe that they have to wait more than a moth after hospital 
discharge to start exercise at home. 
 
All patients need guidance about the intensity, frequency, and 
type of exercise to do at home following discharge from the 
hospital after a major pulmonary insult.  Without professional 
guidance and parameters, patients are often afraid to proceed 
with activity; consequently, weakness, sedentarism, and a risk 
of hospital readmission may occur. 
 Needs of suggestion  for  training progression 
 
This depends on the status of the patient. Even after hospital 
discharge the severity and impairment vary largely among 
COVID-19 patients. Some have been in the intensive-care unit 
for weeks and are highly impaired while some are in relative 
good status. For the latter, low/moderate-intensity physical 
exercise could be done without measures of exceptional 
desaturation. However, in more severe patients information on 
desaturation during exercise is more important. 
 It's difficult to recommend either or, the intensity needs to be 
individualized.  
 
I agree only if the therapist is sufficiently safe from infection. If 
possible, we should consider the introduction of remote 
pulmonary rehabilitation. 
 Using Borg's CR-10 or Borg's RPE 
 Formal exercise assessment should be done even if from 
remote 
 Only if the daily acitivities are going well. If not, do not give the 
recommendation.  
 Depending on age, severity of COVID-19, and past medical 
history. 
 The patient need a continuous process. 
 
The sequelae of the disease are not yet well documented, the 
compromise of the cardiovascular and pulmonary systems are 
a challenge for professionals who prescribe exercise, It is 
necessary to identify oxygenation at rest and in effort in order 
to establish goals or risks 
 to subjective tolerance and monitoring when equipment is 
available.  
 
would not recommend formalized physical exercise routine 
without an exercise and safety assessment with assessment 
of O2 saturation 
 Very essential in order to determine exercise tolerance during 
rehabilitation. 
 I don't think it would be prudent to prescribe any exercise w/o 
assessing oxygen requirements 
 I have not enough knowledge to say if 6-8 week is a correct 
time frame.  
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should patients with COVID-19 have a formal 
assessment of physical and emotional functioning at 
6-8 weeks following discharge, to identify unmet 
rehabilitation needs? 
 Comments   
What we have learned in our hospital is the spectacular range 
in clinical functioning of patients in the recovery phase. Some 
patients although hospitalized but without (very) severe oxgen 
transport deficiency during the acute phase show marked 
functional limitations in the recovery. The opposite may be 
true as well. These insights hold a strong plea to assess 
health status some time after the acute phase to enable 
customized rehabilitation care 
 
Besides screening for physical and emotional/psychological 
impairments in functionining, in patients who have been 
admitted to an Intensive Care Unit Cognitive functions should 
also be assessed.  
 
Depends upon the severity of the illness and the premorbid 
condition of the patient e.g. if elderly and already have 
significant mobility limitations there will be little likely gain from 
formal evaluation of physical function 
 
This would seem a sensible time frame to balance natural 
recovery but not leaving things too long before intervention to 
intervene where needed. However, by formal assessment I 
would advice standardised phonecall first to understand 
ongoing symptoms, mental health issues, lifestyle issues etc 
as a triage and then 'formal' assessment for those where a 
deficity in physical or emotional functioning is detected.  
 
This is a composite question.  The first part is about need for 
formal assessment and the second is about timing.  This may 
complicate interpretation of responses to this survey.  Some 
may agree with formal assessment, but not agree with the 
proposed timing. 
 
The impact of COVID-19 on patients with chronic respiratory 
diseases could be detrimental especially coping aftermath 
(admitted to the hospital).  We know from the published 
literature COPD patients experience high level of anxiety and 
depressive symptoms during hospital admission. Thus, it is 
important to assess their psychological, emotional,  cognitive, 
and psychosocial needs in their daily activities. This is 
particularly important for COVID-19 patients.  
 Assess other aspects that may have been missed early 
(emotional , cognitive , fatigue , myalgia etc) 
 
Definitely. Based on earlier post ICU studies (Recover 
Program NEJM) we can expect both to be affected. We tend 
towards the easier for us -namely physical dysfunction but 
should be equally available for the emotional needs. 
 
After a this time, I believe that we need to assess functional 
capacity and determine the exercise intensity for 
supervisioned or non supervision rehab. 
 
At this point, patients who have had guidance to initiate low to 
moderate level activity during the first 6 weeks following 
hospitalization, are usually ready to increase the intensity of a 
supervised exercise program.  This program should include 
education, assessment of psychosocial status, and monitored 
strengthening, flexibility, and aerobic exercise. 
 
I think it should be better also a quick evaluation at hospital 
discharge ( before the 6-8 weeks) in order to address patients 
to right setting ( home or rehabilitative enviroment) 
 It is highly important to have a thorough assessment in order 
to individualize rehabilitation needs 
 
This does not routinely occur for post-ICU cohorts but may be 
an important part of post-ICU care - but again I'm not sure 
COVID19 patients ought to be treated differently from other 
ICU survivors because there is a risk of losing all the valuable 
research that has occurred in this setting. Based on this prior 
literature (e.g. Post-Intensive Care Syndrome), there may also 
be other important domains for assessment at 6-8wks e.g. 
cognitive function, return to work etc. 
 We need to identify at discharge the patients Who need this 
assesment at 6-8 weeks  
 
Recommend 6-8 week (telephone/video) review to screen / 
triage, then more structured physical, functional and 
psychological review at 12 weeks. 
 
Only an assessment if they say that they still have physical of 
emotional problems. Or if the physiotherapist of doctor thinks 
it is necessary.  
 
The evidence for other like-conditions indicates long term 
physical and emotional issues as a result of the illness - this 
could be improved for COVID-19 if these assessments took 
place. 
 
We need to have measure to evaluate the effectiveness of the 
COVID-19 rehabilitation and it is important for the longitudinal 
follow-up, also. 
 The recommendation will depend on the conditions of the 
pandemic in each country, and the mobility and safety 
restrictions for patients; During the first few weeks there could 
be a risk of complications if the patient had a prolonged ICU 
stay (as shown with COVID patients). If the conditions are met 
patients with clinical or imaging evidence of sequelae should 
be prioritized https://pubmed.ncbi.nlm.nih.gov/32227758/.  
 
 
 
Telephone strategies should be taken into account 
 for those that still showing deficits, functional limitation and or 
tolerance 
 
Given the existing literature and evidence base regarding 
prolonged manifestations of critical illness, I think survivors of 
COVID 19, particularly those who have had illness severe 
enough to receive care in the ICU (with or without mechanical. 
ventilation), are likely to have some quite prolonged changes 
in physical, emotional and/or cognitive function; it will be 
important to routinely assess this to guide optimal strategies 
for rehabilitation. 
 
There may be some restrictions related to activity level at this 
stage. If there is a possibility for close contact use of personal 
protective equipment may be required. Assessments requiring 
light efforts may be performed.  
 Absolutely necessary. 
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should follow up of a hospitalised patient with 
COVID-19 include the core outcomes set (e.g., EQ-
5D, Hospital Anxiety and Depression Scale, Impact of 
Events Scale-Revised, PMID: 28699762) for survivors 
of acute respiratory failure at 6-8 weeks following 
hospital discharge? 
 Comments   
I'm not an expert, but my feeling is that a more generic 
instrument on physical functioning for example SF-36  
together with the EQ-5D could give a more comprehensive 
picture of the consequences. 
 Instead of the IES-R, the PC-PTSD-5 , a brief screening 
questionnaire should be used to evaluate symptoms of PTSS  
 
6-8 weeks may be too soon for IESr as PTSD often does not 
show early so it can be done at this time point but should also 
be done at 12 months.  HADS is important and I would echo 
thoughts for EQ-5D as above - repeat at 6 and 12 months 
 Public healthy questionnaire 9 is recommended by mental 
health professionals to replace HADS 
 
EQ-5D - yes  
 
Need an assessment of exertional breathlessness - MRC 
dyspnoea scale as a minimum  
 
I don't have experience with the impact of events scale 
 
(aware of COMET) 
 mood disorder and ptsd is common (occurs up to 1/3) in  
patient in critical cre 
 
This comment is from Dale Needham who is first author of the 
paper mentioned below. 
 
 
 
I think we need to separate out the recommendation for type 
of outcome assessment and the timing.  For instance, some 
people may agree with the measurement instrument, but not 
with the proposed timing.  This question is worded as a 
composite recommendation which generally should be 
avoided in these types of consensus/survey questions. 
 
 
 
Moreover, i think you are trying to cite the Core Outcome 
Measurement Set paper in AJRCCM, but i tihnk that the 
PMID, above, is not correct.  Don't you mean: PMID: 
28537429  American Journal of Respiratory and Critical Care 
Medicine, 31 Oct 2017, 196(9):1122-1130 
 
DOI: 10.1164/rccm.201702-0372OC PMID: 28537429 PMCID: 
PMC5694837  
https://www.atsjournals.org/doi/10.1164/rccm.201702-0372OC 
 
 
 
I agree with the suggestion to use outcome measures 
proposed to use in the follow-up patients at 6-8 weeks. I also 
wonder to include a scale that include 'fear' and 'stress' for 
patients with respiratory diseases. These are big problems 
often overlooked by healthcare professionals. I know the 
Depression Anxiety Stress Scale (DASS-21) measure has 
been used in patients with respiratory disease e.g. COPD. 
This might be a potential scale to include in the 
recommendation. Administering these outcome measures will 
help to identify the patients' need in order to  direct, plan and 
devise appropriate interventions  and resources to the patients 
and their caregivers especially for older people 
 
Outcomes are important. The exact choice of which represent 
"core" will vary and should be allowed to do so, with local 
modification of test selection based on experience and data 
collection.. 
 For sure! 
 This was rigorously conducted research so yes, important to 
use this research and avoid research waste! 
 Again is the assesment at discharge that drives the following 
steps  
 
Yes recommend bit at 12 weeks. 
 
 
 
Yes EQ-5D and measures for anxiety, depression and post 
traumatic stress, in UK often use GAD-7 and PHQ-9. 
Recommend PTSS-14 or IES-R (or equivalent). Also need 
cognitive screen if relevant e.g. MoCA. 
 More suggestions: 
 
- RAND-36 (Orwelius 2018). 
 
- International Physical Activity Questionnaire-Short Form 
(IPAQ). (Ekelund et al., 2006) 
 
- Cognitive function, The Montreal Cognitive Assessment 
MOCA eller  The Rowland Universal Dementia Assessment 
Scale RUDAS)  (Nasreddine et al 2005).  ICU memory Tool 
(Jones et al 2000). 
 
- Fatigue (Mental Fatigue Scale, MFS)  (Johansson et al 
2010) 
 
- Clinical Frailty Score (CFS)  (Dalhousie University) 
 
- Patient Health Questionnaire-9 (PHQ-9). S Kroenke, K., 
Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity 
of a brief depression severity measure. J Gen Intern Med, 
16(9), 606-613.. 
 
- Generalised Anxiety Disorder 7-item scale (GAD-7). (Spitzer, 
2006). 
 
- The Posttraumatic Stress Disorder Checklist for DSM-5 
(PCL-5)  Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, 
T. K., & Domino, J. L. (2015). The Posttraumatic Stress 
Disorder Checklist for DSM-5 (PCL-5): Development and 
Initial Psychometric Evaluation. J Trauma Stress, 28(6), 489-
498. doi:10.1002/jts.22059 
 
- The Short Health Anxiety Inventory (SHAI). S (Salkovskis, 
Rimes, Warwick & Clark, 2002). 
 
The follow up can be done by the hospital or by the other 
medical care providers. Not every patient with COVID-19 was 
hospitalised.  
 It is very useful. 
 it would be necessary to consider the execution of self-
directed questionnaires 
 
also need objective physical measures as well to fully 
understand recovery  
 
This is a likely useful starting point to assess patients who 
have survived acute respiratory failure. Additional, novel 
outcomes may also be important to add given the spectrum of 
manifestations of COVID-19 and the potential for unique 
challenges related to rehabilitation for and recovery from it.  
 Absolutely necessary 
 I believe this should also be done further out to 3/6/12 mo 
 If those measurements are of relevance for this Group of 
patients.  
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
Should follow up of a hospitalised patient with 
COVID-19 include measures of respiratory function 
at 6-8 weeks following hospital discharge? 
Comments 
The first reports of long-term consequences from Italy and 
China of COVID-19 have learned that in many patients there 
is a lasting impact on the respiratory tract.  
Probably too soon to understand long term sequelae.  
 
Currently no definite support that 100% safe to do - seek 
virology advice 
to excluse permanent affects on lung elasticity unless there is 
radiological/lung function evidence of same 
Not sure what 'respiratory function' consists of or what those 
assessments would be. Having said this, missing any negative 
respiratory findings are likely to lead to decline or 
rehospitalization. 
There is not enough information for me to respond to this 
question.  "Measures of respiratory function" seems a bit too 
vague - do we mean spirometry or do we mean a patient 
survey or either? 
We know that lung function does not change significantly in 
those who are stable with optimal medical treatment 
especially those with COPD etc. In my view, if the patient has 
lingering respiratory symptoms it is important to repeat the 
lung function test  to determine the severity of the disease 
where appropriate.  
Suggest defining "respiratory function" before I could better 
answer.  
yes assuming COVID negative tested. 
We don't know yet about how many days the virus stays at 
respiratory systems, so, I am not sure about to assess the 
lung function in these patients. 
This would be a good time to assess the residual lung 
damage that occurred as a result of COVID as well as monitor 
the recovery process. 
Not sure about infective risk ( dedicated filter? sanification of 
device?) 
Yes, to get an indication of the natural recovery in respiratory 
function 
I agree only if the therapist is sufficiently safe from infection. 
Including KCO and 6 MWT 
Spirometry and maximal inspiratory and expiratory pressure 
Not for every patient. Only if there arre still problems and you 
suggest that the problem is based on respiratory disfunction.  
It is very important because of the impairment of the lung 
parenchyma and chest wall. 
The performance of pulmonary function tests should be 
subject to the urgent need to make therapeutic decisions, 
especially in countries where there is a considerable increase 
in cases. 
 
 
 
https://www.thoracic.org/professionals/clinical-
resources/disease-related-resources/pulmonary-function-
laboratories.php 
However it should be necessary to do a PCR assessment with 
a negative result.  
Yes this is desirable provided that: 
 
1. it is felt to be safe for the patient (ie no contraindications to 
performing testing) 
 
2. pulmonary function testing can be performed with adequate 
protection for staff--we do not really know anything about 
when it is safe to reopen pulmonary function laboratories and 
whether there could be any delayed transmission of covid 
from performing testing on COVID survivors (ie ? any potential 
for transmission of lingering COVID) 
There may be risk of equipment contamination.  
absolutely necessary, biosafety protocols must be taken into 
account to avoid cross contamination. 
it is unclear if equipment will be available at this time to 
perform a full assessment of respiratory function 
I think this is too soon 
If it can be conducted safely.  
 
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should follow up of a hospitalised patient with 
COVID-19 include measures of exercise capacity at 
6-8 weeks following hospital discharge? 
 Comments   
Exercise capacity should not be assessed in all patients that 
were hospitalized;  only on indication .  
 As per prior question not for elderly patients who have pre-
morbid limitations  
 Baseline ECG  
 
Need to ensure team are aware of any risk of 
cardiomyopathy/pe's from the admission or where there's 
ongoing breathlessness where full medical review hasn't yet 
been undertaken. This is unlike most other rehabilitation 
situations where the medical sided of things are optimised 
first.  
 
Ongoing investigations for cardiac, renal, respiratory 
impairment likely to occur 3 months or beyond to give time for 
triage of those naturally recovered vs. on going 
symptoms/radiological findings.   
 allows assessment of diablity 
 
The answer to this question may vary, considerably, based on 
the severity of illness for the patient.  The work place of the 
respondent may lead to assumptions about this, since the 
severity was not specified.  For instance, those working in an 
intensive care unit, may presume that we mean patients from 
an ICU.  We have had more than 1200 COVID-19 patients at 
my hospital, alone, and some may only stay for a couple of 
days, on the regular medical floor, and then be discharged to 
home. My response will highly vary based on the severity of 
the patient illness as was specified in question 6. 
 Agree, it is very important to do so.  
 After ruling out cardiac problems  
 
Depends on definition of exercise capacity. A measure of 
exercise is valuable at this time but formal incremental 
laboratory based exercise may not be essential.  
 For sure, to determine exercise intensity and to follow up 
functional capacity. 
 A simple exercise test, such as a 6 minute walk test, would 
guide continued activity recommendations. 
 Not sure about the time of first evaluation ( why not before ?)  
 
Choice of strategy to assess exercise capacity needs to be 
individualized  
 6-min walk test and 30 sek chair stands test, handgrip 
strength (JAMAR) and SPPB 
 Yes. 
 Maximal exercise capacity and physical activity are very 
important. 
 Functional exercise capacity  
 
The carrying out of exercise capacity tests should be subject 
to the state of the countries; however, in optimal conditions of 
safety for patients and professionals, it is necessary to have 
evaluations of exercise capacity in patients with clinical or 
imaging evidence of sequelae 
 However it should be necessary to do a PCR assessment with 
a negative result.  
 
Yes, but the measures used will depend on the functional 
status of patient. For many this may mean simple things such 
as sit to stand testing, 6 min walk (as able), dowel lifting. Many 
patients may not be ready for incremental exercise testing 
such as incremental shuttle or CPET 
 I am not sure about six minute walk test or similar test, or less 
demanding tests. 
 Highly recommended 
 it is unclear if equipment will be available at this time to 
perform a full assessment of exercise capacity  
 This might be a bit early but this assessment is crucial 
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should COVID-19 survivors with a need for 
rehabilitative interventions at 6-8 weeks following 
hospital discharge (e.g., multiple treatable traits) 
receive a comprehensive rehabilitation program, 
compared to no rehabilitation program? 
 Comments   
In my opinion, should all patients reporting dysfunction 6-8 
weeks after discharge receive an assessment enabling to 
provide individualised rehabilitation. The first clinical 
experiences show a marked diversity in needs. 
 Individually tailored based on need -agree. Not all survivors 
will need a comprehensive programme.  
 
Stratify by severity of acute illness - all ICU, all higher 
respiratory support ... triage everyone else? 
 duty of care as well as strongly supported by international 
guidelines 
 Depends on community prevalence of COVID.  
 It seems logical- evidence is pending 
 Research has supported Pulmonary Rehabilitation as an 
affective intervention for lung disease. 
 
Our experience is that Covid-19 patients who are very 
heterogeneous having both psychological and physiological 
needs.  
 I think it’s depend on the patient’s conditions(like age, 
comorbidities, severity etc). 
 
I agree only if the therapist is sufficiently safe from infection. If 
possible, we should consider the introduction of remote 
pulmonary rehabilitation. 
 Similarly to other patients 
 
Recommend follow up in dedicated critical care clinic with 
integrated respiratory review and multi disciplinary input with 
referral to further specialist services as required e.g. 
community physio, neuro rehab, pulmonary rehab etc. 
 
If there is a  need for a rehabiliation programme, because the 
patient physical and/or emotional and/or cognitive problems. It 
is better to treat the patient in rehabilitation programme with 
different medicale care providers.   
 In compliance with safety requirements and inclusion criteria, 
patients should receive pulmonary rehabilitation. 
 
Sure, however it is important take into account the different 
situation in each country regarding the lockdown and the 
availability of services such as tele-rehabilitation or similar. 
 
Individualization of rehabilitation intervention will be as 
important as ever, and additional safeguards may prove to be 
needed, above those delivered typically in post-hospitalization 
rehabilitation, eg depending on what effects the virus has had 
on the patients' heart, lungs, muscles etc 
 Intensity may need revision for the active components. 
 Perform as long as the no treatment group with pulmonary 
rehabilitation can then benefit from the intervention. 
 
again, it is unclear if rehabilitation program will be available at 
this time to perform a full , and save conventional program, 
but strategies must be put in place to cover the needs 
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should COVID-19 survivors with pre-
existing/ongoing lung function impairment at 6-8 
weeks following hospital discharge receive a 
comprehensive pulmonary rehabilitation program 
consistent with established international standards, 
compared to no pulmonary rehabilitation program? 
 Comments   
Depending on patient preferences and needs 
 established international standards are for a totally different 
disease 
 
symptoms / mental health/ lifestyle should drive the 
assessment not spirometry 
 
even to assess lung function transfer factor likely to be a 
better assessment of respiratory impairment as the infiltrates 
are alveolar based not a large airways disease (there may be 
small airways disease of course but spiro may miss those 
too).  
 Would depend on the extent of any pulmonary findings or 
limitations. 
 Depends on community prevalence.  
 
Pulmonary Rehabilitation, including supervised and monitored 
strengthening/flexibility/and endurance exercise and education 
is an affective treatment for lung impairment.  PR is 
recognized by the American Thoracic Society, European 
Respiratory Society, and in the USA Medicare national health 
care system as a recommended intervention for lung 
impairments. 
 A rehab program for this group need to be indiviualized. 
 I agree only if the therapist is sufficiently safe from infection.  
 Yes, after lung function measurements.  
 We need it because of functional impairments. 
 
Patients should return to their pulmonary rehabilitation 
activities, as the exercise prescription and activities needed by 
these patients must be organized by a comprehensive 
rehabilitation program. 
 yes, but with same caveats as noted for question 9 
 
The patients may be more fragile than a typical acute 
exacerbation. The intensity of the active components and 
outcomes may need revision 
 
Perform as long as the no treatment group with pulmonary 
rehabilitation can then benefit from the intervention. 
 I think that some patients could not be able to do a pulmonary 
rehabilitation program following the international guidelines. 
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should COVID-19 survivors with loss of lower limb 
muscle mass and/or function at 6-8 weeks following 
hospital discharge receive a muscle strengthening 
program, rather than no strengthening program? 
 Comments   
On indication and depending on pts needs and preferences  
 
It would be good to offer respondents, the option of No 
Response- this is a "norm" for consensus process given that 
some respondents may feel that they don't have adequate 
expertise to respond to a question or they may not understand 
the question wording. 
 Depends on community prevalence.  
 
This needs to be supported with the available literature 
especially to the major muscle groups. A significant older 
COPD patients experience falls and it is important to focus on 
exercises that improve muscle strength and balance in 
patients with COVID-19. 
 The muscle strength assessment has to be performed before 
start the program. 
 
Over the past 9 decades, physical Therapy has been shown 
to assist with the rehabilitation and recovery of weak muscles, 
ambulatory impairments, independent self-care, and 
resumption of physical function in patients with 
cardiopulmonary, neuromuscular, and musculoskeletal 
impairments.   
 
I agree only if the therapist is sufficiently safe from infection. If 
possible, we should consider the introduction of remote 
pulmonary rehabilitation. 
 No recovery without strengthening program.  
 We need to focus on muscle strength. 
 It has been documented that patients with prolonged stays in 
the ICU have musculoskeletal sequelae, especially in the 
lower limbs. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525229/.  
 
 
 
Assessments should be conducted after an adaptation period 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234392/ 
 Optimal intensity and duration to be determined--again need 
to ensure we are not causing any further harm to muscles 
 
Light workloads may be required to use. Monitorization of 
perceived effort, level of dyspnea and cough may be advised. 
 Absolutely necessary. 
 
Maybe it should be differentiated if COVID-19 survivors 
perceive also Limitations in their activities of daily living (this 
might be more important than "just" measuring muscle 
strength) 
  
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
Should COVID-19 survivors with loss of lower-limb 
muscle mass at 6-8 weeks following hospital 
discharge receive nutritional support rather than no 
nutritional support? 
Comments 
Rebuilding muscle mass requires a training stimulus and the 
right nutrients 
I would recommend to screen all pts that were hospitalized on 
nutritional status. We use the Snaq in the Netherlands. In our 
experience, around 80% of pts that were admitted to an ICU 
are malnourished after hospital discharge.  
 
Refer tot dietician on indication.  
Others are more expert in this area to advise.  
 
Practical advice regarding protein intake and healthy eating 
would seem reasonable - thought there was only limited 
evidence for any specific nutritional supplementation in other 
'chronic diseases'? Don't think we understand the deficit 
enough yet to be more  
 
Obesity is the major issues we've seen in inpatients (might be 
another question coming up). 
 
Definitely focusing on lifestyle factors smoking cessation, 
physical activity, sleep would seem sensible  
dietitian review required 
This question is a bit too vague for me to respond. 
I agree to have appropriate guidance  and evaluation about 
their nutritional need from a dietician, especially those who are 
undernourished.  
De Bendette describes advantages with Q10 and creatine in 
COPD 
"Nutritional support" should be defined. Do you mean "should 
receive consultation of a medical-based registered/licensed 
dietician"? If so, my answer is conditional rec "for" 
Depends on their nutritional status. Nutritional support-in the 
form of a clinical assessment could be useful but supporting 
all patients as a routine might be a lot less so. 
Specially for the patients who had sepsis during ICU stay. 
Other assessments need to be done to assess if nutritional 
support are required. Cant be based only on the loss of lower-
limb muscle mass.  
I agree only if the therapist is sufficiently safe from infection. If 
possible, we should consider the introduction of remote 
nutritional advice. 
No data available  
It is always good the check de nutrional intake. If you analyse 
that the proteins are to low, it is a recommendation for 
nutritional support. Otherweise you can give the patient 
strength training, but the effect is to small. Look at the 
guidelines of sarcopenia.  
Nutrition is very important in this field. 
Patients with COVID, who have malnutrition are more at risk 
of complications 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138149/; and 
as it is well known that patients with chronic lung disease must 
have a well-applied nutritional regimen, COVID survivors must 
have an energy substrate to carry out activities involving 
metabolic increase 
would provide nutritional support to those with loss of muscle 
mass and other features to suggest nutritional depletion such 
as low serum albumin level, and as complementary 
intervention to other aspects of rehabilitation 
There is not much evidence in other types of pathologies 
I think this may be a bit less well established in most centers 
and guidance would be needed from expert sources 
 
  
COVID‐19: Interim Guidance on Rehabilitative 
Interventions in the Post-Hospital Phase 
Pending Empirical Evidence 
 
Should COVID-19 survivors with symptoms of 
psychological distress (using questionnaires) at 6-8 
weeks after discharge from the hospital receive a 
formal psychological assessment? 
 Comments   
Some degree of psychological distress after going through a 
serious illness seems normal to me. I do not feel like an expert 
to indicate when it would require specific intervention 
 
Symptoms of anxiety, depression and PTSD are considered to 
be normal in persons after a major life event. Screening and 
monitoring of the course of symptoms is important. Treatment 
is indicated when symptoms continue to exist after 10-12 wks.  
 Follow existing guidance for mental health  
 
Expect this will be very prevalent in COVID19 for a variety of 
reasons  
 This is paramount, given the mounting evidence for 
PTSD/PTSS following critical care stays. 
 
This recommendation needs to be qualified as follows: 1) The 
first thing is to administer a screening tool such as the HAD 
scale or PHQ-9 etc.  2) Those who showed high level of 
anxiety or depressive symptoms needs to be referred to 
psychologist or psychiatrist for further assessment. 3) If there 
are no resources or expertise available, it is important to 
monitor the patients psychological status, periodically by the 
therapist or healthcare professionals .  
 We saw a lot of patients with psychological problems after 
Covid- 
 
Perfusion defects (NEJM) in frontal and temporal Brain parts  
could Be an explanation  
 
Depends on who is assessing and at what level of 
sophistication. The issue is that any assessment should 
preseed management and the necessary skills should be 
accessible. 
 For sure! 
 
This is outside of my competence whether a formal 
psychological assessment is required if  COPD-19 survivors 
have symptoms of psychological distress. For me, it depends 
on the degree of symptoms.  
 
Yes - if able to resource 
 I think that psychological assessment for the family of the 
infected patient is also necessary. 
 
Recommend this at 12 weeks. Steep recovery over first 6 
months, aim to support recovery and self management with 
good information to help patients and families understand the 
normal constellation of acquired problems associated with 
severe / critical illness and impact on family. 
 You see in the clinical setting that a lot of COVID-19 patients 
have symptoms of anxiety, depression and stress. 
 
Psychological support is very important in this severe disease. 
 
Interventions are necessary, especially in this crisis that is 
completely new and devastating for many 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153528/ 
 
Ideally yes, but patient preference will need to play a role, as 
not all people with symptoms of psychological distress may 
wish a formal assessment 
 Absolutely necessary 
  
